Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jun 1;16(6):e0252307. doi: 10.1371/journal.pone.0252307

Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study

Ghulam Qader Qader 1,*, Mohammad Khaled Seddiq 2, Khakerah Mohammad Rashidi 1, Lutfullah Manzoor 2, Azizullah Hamim 1, Mir Habibullah Akhgar 2, Laiqullrahman Rahman 2, Sean Dryer 3, Mariah Boyd-Boffa 4, Aleefia Somji 3, Muluken Melese 3, Pedro Guillermo Suarez 3
Editor: Ramesh Kumar5
PMCID: PMC8168887  PMID: 34061873

Abstract

Background

About 26% of the world’s population may have latent tuberculosis infection (LTBI). Health care workers are a high-risk category because of their professional exposure.

Methods

This cross-sectional study assessed the LTBI burden among health care workers in Afghanistan, a high-TB-burden country. We selected health facilities using a systematic sampling technique and invited all workers at the targeted health facilities to participate. Participants were interviewed about sociodemographic and exposure variables and received tuberculin skin tests for LTBI.

Results

Of the 4,648 health care workers invited to participate, 3,686 had tuberculin skin tests. The prevalence of LTBI was found to be 47.2% (1,738 workers). Multivariate analysis showed that a body mass index of ≥ 30 and marriage were associated with an increased risk of LTBI. Underweight (body mass index of ≤ 18 and below) and normal body mass index had no association with increased risk of LTBI.

Conclusion

LTBI is high among health care workers in Afghanistan. We recommend instituting infection control measures in health facilities and screening workers for timely TB diagnosis.

Background

In 2017, 10 million people developed tuberculosis (TB) and 1.3 million succumbed to the disease [1]. An estimated 2 billion people worldwide—26% of the global population—are believed to be infected with TB [1]. Of the 10 million estimated TB incident cases, about 4.4 million prevalent cases are found in the South-East Asia region [1]. Afghanistan has a prevalence rate of 340 and incidence rate of 189 per 100,000 population. In 2019, Afghanistan’s National TB Program (NTP) diagnosed and reported 48,420 TB cases of all forms (73% of estimated incident cases) [1]. Although Afghanistan has a treatment success rate of 91%, the World Health Organization (WHO) estimates that 12,000 Afghans still die of TB annually, although in 2019 TB mortality declined to 9,800 [1, 2].

The only sign of TB infection is a positive reaction to the tuberculin skin test (TST) or a blood test. Persons with latent TB infection (LTBI) are not infectious, but having a TB infection is a precondition for having TB disease, and 5% to 10% of those infected could develop the disease in their lifetimes. The majority of those cases will develop within five years of infection [3]. Twenty-three percent of the world’s population is estimated to have LTBI (based on TST), which represents a huge reservoir of potential TB disease and is therefore a challenge to TB control [4].

To control TB effectively, it is important to know the burden of TB infection among health care workers (HCWs), who are at higher risk of TB infection due to exposure to diagnosed and undiagnosed TB patients [58]. This risk is proportionally more alarming in low- and middle-income countries because of both increased exposure and lack of preventive measures, such as poor workplace ventilation and inadequate precautions during sputum collection and bronchoscopy [9]. Occupational risk factors associated with LTBI include duration of employment in a health care profession [5, 1014]; being a nurse, diabetic, or smoker [11]; being over the age of 35 [15, 16]; employment in cleaning or housekeeping and in a health care setting with high patient turnover [17]; having been employed in an HIV clinic or ward [12]; and not having had a Bacille Calmette-Guérin vaccination or being immunocompromised [18].

In a systematic review of TB studies among HCWs in South Africa, most reflected a higher incidence and prevalence of active TB disease in HCWs, including drug-resistant TB, compared to the surrounding community or general population [19]. A review of HCWs in seven countries with high TB prevalence (> 100/100,000 population) reported an LTBI prevalence rate of 47% [20].

Through this study, we sought to address the lack of information on estimates of TB infection among HCWs in Afghanistan. The findings can assist the NTP and Ministry of Public Health to shape policy to ensure a safer working environment for HCWs.

Methods

Study design and population

This cross-sectional study among HCWs was conducted in 23 provinces of Afghanistan between September and December 2017. “Health care workers” for this study included any worker in the health facility: doctors, nurses, laboratory professionals, midwives, vaccinators, community health workers, cleaners, guards, administrative staff, and others. The sample size for the study was determined using a single proportion formula [21] assuming an LTBI prevalence (pone`) of 47% among HCWs [20], type I error of 5%, and desired precision of 0.05, and a response rate of 60%. The resulting sample size was 1,281 HCWs. All 2,499 health facilities in Afghanistan—public, private, and prison—are listed in the national health information system register and a systematic random sampling technique to select study facilities. Assuming an average number of five HCWs per health facilities, and no difference in LTBI between health facilities, the total number of health facilities required to obtain the sample of HCWs was 249. Health facilities were listed in alphabetical order and every 10th health facility was included in the study, the first one being picked by lottery method among those health facilities listed from 1–10. All HCWs in the randomized health facilities were then included as potential participants.

Training of data collectors

The data collection tool was developed in English first and translated into local languages (Dari and Pashto) and then retranslated into English by a third person who was not involved in the drafting of the first version to check the consistency of the questionnaires. The local language version was then administered to 50 health workers to check for clarity, consistency, and ease of understanding. Following this the actual data collectors, who were unemployed HCWs, were trained to pilot-test the questionnaires, which included sociodemographic and exposure variables, with study participants. Physicians with experience in administering TST were trained by the principal investigator (GQ) to follow study procedures under supervision to administer the test to 120 HCWs, as indicated in the study procedures below. The inter-observer agreement level for TST skin induration measurement was determined and the weighted Kappa value was 0.75. Twenty-two physicians with perfect skills were selected to conduct TSTs for the study.

Study procedures

Data collectors administered the questionnaires, which included HCWs’ history of active TB and of TSTs, followed by screenings for active TB symptoms and signs, such as a cough lasting two weeks or more, night sweating, and weight loss. Those with signs of TB were asked to give a sputum sample for GeneXpert testing (Xpert MTB/RIF assay, Cepheid, Sunnyvale, USA). All HCWs with TB constitutional symptoms also received a chest X-ray.

HCWs without signs or symptoms of TB and with no history of active TB were administered 0.1 ml of 5 tuberculin units of purified protein derivative (BB-NCIPD Ltd., 1504 Sofia, Bulgaria) intradermally in the volar surface of the forearm [22]. Trained physicians read the TST induration within 48–72 hours of administration.

Exclusion criteria

HCWs with presumptive TB and those with a history of active TB were excluded, as were those who did not volunteer for the TST test.

Interpretation of TST results

Per the NTP’s definition, the following cutoff points were used to interpret the skin test: CHWs with induration of ≥ 10 mm at 48–72 hours were considered to have LTBI, those with a reading of 0–9 mm and were HIV negative were considered negative for LTBI. If the CHW was HIV positive, 5–10 mm was also considered LTBI [22].

Data entry and analysis

The data were entered in Epi Info version 7.2.2.6 and transferred to SPSS version 23 for analysis. A univariate analysis was used to identify potential variables predicating positive TST with Pearson’s chi-square test, and all variables with a P value of less than 5% in the bivariate analysis were further analyzed with multiple logistic regression analysis to determine any associations. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were used to determine the association with sociodemographic and exposure variables. In the calculation of the odds ratios, missed variables were excluded.

Ethical considerations

The study was approved by the Afghan Ministry of Public Health Institutional Review Board under approval number 43864, dated August 2, 2017. Study participants were properly instructed in local languages (Dari or Pashto) about the study purpose, the procedures to administer TST and possible side effects related to the injection site. After these explanations, all the study participants gave written consent in Dari or Pashto. Their information was kept confidential and not shared with anyone outside of the study team. The data set had no personal identifiers. Those who did not consent were excluded from the study. Those with signs of TB were provided a free diagnosis, and those diagnosed with TB were given free treatment, according to national guidelines.

Results

In total, the 249 health facilities sampled had 4,648 health workers, and, of these, 3,975 (85.5%) consented to participate; 154 (3.3%) refused to participate; 474 (10.1%) were excluded from the study because they were presumptive TB cases; and another 45 (0.9%) had a history of TB. We gave TSTs to 3,975 HCWs and read results for 3,686 (92.7%); 289 HCWs (7.3%) did not return for the reading and were excluded from the analysis (Fig 1).

Fig 1. Flow chart showing health care workers who participated in the LTBI study in Afghanistan.

Fig 1

In this study, male HCWs constituted 2,573 (69.8%) of participants. The mean age of study participants was 34.5, with a median age of 32. Of the participants, 2,923 (79.3%) were married, 2,152 (58.4%) were college or university graduates, and the average monthly income of 1,616 (43.8%) was less than US$130. In 1,966 (53.3%) of participants, body mass index (BMI) was normal (18–24.9); 1,195 (32.4%) were overweight (BMI = 25.0–29.9); 237 (7.4%) were obese (BMI = ≥ 30); 115 (3.1%) were underweight (BMI = < 18); and in 134 HCWs (3.6%), measurements were not taken.

Of 3,686 test results, 1,738 were LTBI positive, for a prevalence of 47.1% (95% CI 45.4%-48.7%). Men had a higher TST positivity—a total of 1,237 (71.3%)—than women, of whom only 497 (28.5%) tested positive, but the difference was not statistically significant (P > 0.05). In the bivariate analysis, the only groups that showed significant associations with LTBI were married (OR = 2.13, 95% CI 1.77–2.57), aged between 35 and 44 (OR = 1.30, 95% CI 1.07–1.57), and illiterate (OR = 1.34, 95% CI 1.06–1.7) (Tables 1 and 2).

Table 1. Sociodemographic variables and association with LTBI among health care workers in Afghanistan (N = 3,686).

Variables TST Positive (≥ 10 mm) TST Negative (0–9 mm) P Value
Sex Male 1,237 (71.1%) 1,336 (68.8%) P = 0.054
Female 497 (28.6%) 601 (30.9%)
Missing data 4 (0.2%) 11 (0.6%)
Total 1,738 (47.1%) 1,948 (52.9%)
Age 18–24 372 (21.4%) 441 (22.6%) P = 0.025
25–34 530 (30.5%) 601 (30.9%)
35–44 435 (25.1%) 398 (20.4%)
45–54 260 (15.0%) 336 (17.2%)
55–64 109 (6.3%) 128 (6.6%)
≥ 65 14 (0.8%) 20 (1.0%)
Missing data 15 (0.9%) 39 (1.2%)
Total 1,738 (47.1%) 1,948 (52.9%)
Marital status Married 1,490 (85.9%) 1,433 (73.6%) P < 0.001
Single 208 (12.0%) 481 (24.7%)
Separated 1 (0.1%) 3 (0.2%)
Not mentioned 27 (1.6%) 15 (0.8%)
Missing data 9 (0.5%) 16 (0.8%)
Total 1,735 (47.1%) 1,948 (52.9%)
Highest level of education completed Illiterate 192 (11.1%) 170 (8.7%) P = 0.005
Primary school 198 (11.4%) 199 (10.2%)
Secondary school 259 (14.9%) 289 (14.8%)
College or university graduate 962 (55.4%) 1,190 (61.1%)
Other 12 (0.7%) 5 (0.3%)
Missing data 115 (6.6%) 95 (4.9%)
Total 1,738 (47.1%) 1,948 (52.9%)
Professional category Doctor 224 (12.9%) 237 (12.2%) P = 0.205
Nurse 336 (19.3%) 334 (17.1%)
Midwife 151 (8.7%) 219 (11.2%)
Laboratory professional 95 (5.5%) 101 (5.2%)
Community health worker 67 (3.9%) 68 (3.5%)
Pharmacy professional 46 (2.7%) 55 (2.8%)
Vaccinator 123 (7.1%) 114 (5.9%)
Admin. and support staff 607 (35.0%) 715 (36.7%)
Other 70 (4.0%) 83 (4.3%)
Missing data 19 (1.0%) 22 (1.1%)
Total 1,738 (47.1%) 1,948 (52.9%)
Monthly income (in Afghani) < 10,000 777 (44.8%) 839 (43.1%) P = 0.4
10,000–20,000 664 (38.3%) 754 (38.7%)
20001–30,000 161 (9.3%) 168 (8.6%)
30001–50,000 43 (2.5%) 50 (2.6%)
> 50,000 18 (1.0%) 10 (0.5%)
Did not specify 57 (3.3%) 75 (3.9%)
Missing data 15 (0.9% 52 (2.7%)
Total 1,735 (47.1%) 1,948 (52.9%)
BMI (kg/m2) < 18 43 (2.5%) 72 (3.7%) P < 0.001
18–24 882 (50.8%) 1,084 (55.6%)
25–29 603 (34.8%) 592 (30.4%)
30+ 151 (8.7%) 122 (6.3%)
Missing data 56 (3.2%) 78 (4.0%)
Total 1,735 1,948
History of TST Yes 15 (0.9%) 15 (0.8%) P = 0.448
No 1,593 (91.6%) 1,787 (91.7%)
I do not know 130 (7.4%) 182 (9.3%)
Total 1,738 1,948

Table 2. Multiple logistic regression analysis of factors associated with LTBI among health care workers in Afghanistan.

Variables Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Years of professional service < 10 years 1
10–19 years 1.17 (0.99–1.39) 1.18 (0.97–1.44)
20–39 years 0.97 (0.75–1.25) 1.04 (0.77–1.39)
40+ years Insufficient number
BMI (kg/m2)  <18 1
18–24 1.28 (0.84–1.97) 1.20 (0.78–1.87)
25–29 1.68 (1.09–2.60) 1.44 (0.93–2.25)
30+ 2.04 (1.26–3.34) 1.70 (1.04–2.80)
Marital status Single 1
Married 2.13 (1.77–2.57) 1.99 (1.65–2.40)
Separated Insufficient number
Widowed Insufficient number
Not mentioned 1.60 (0.77–3.52) 1.41 (0.66–3.15)
Highest level of education completed Illiterate 1
Primary school 0.88 (0.64–1.19) 0.92 (0.67–1.27)
Secondary school 0.77 (0.58–1.03) 0.87 (0.65–1.17)
College or university graduate 0.72 (0.56–0.91) 0.85 (0.66–1.10)
Age  18–24 1
25–34 1.05 (0.88–1.26) 1.02 (0.85–1.23)
35–44 1.30 (1.07–1.57) 1.18 (0.95–1.46)
45–54 0.93 (0.75–1.15) 0.88 (0.69–1.12)
55–64 1.07 (0.80–1.44) 1.02 (0.74–1.40)
≥ 65 0.85 (0.39–1.79) 0.74 (0.33–1.58)

In the exposure variables, those who had worked in health care for less than 10 years had a higher prevalence of LTBI—1,115 (64.1%)—and the difference was significant (P = 0.04). The prevalence of LTBI was not associated with health facility type, cigarette smoking, or family history of TB (P > 0.05). There were only four reported cases of HIV-positive health workers; the majority (56.7%) of HCWs did not know their HIV status (Table 3).

Table 3. Exposure variables and associated factors among health care workers in Afghanistan.

Variables TST Positive (≥ 10 mm) TST Negative (0–9 mm) P Value
Years of professional service < 10 years 1,115 (64.1%) 1,293 (66.3%) P = 0.04
10–19 years 405 (23.3%) 385 (19.7%)
20–39 years 130 (7.4%) 169 (8.6%)
40+ years 6 (0.3%) 10 (0.5%)
Missing data 82 (4.7%) 91 (4.6%)
Type of health facility worked in Public primary health care units 628 (36.1%) 668 (34.3%) P > 0.05
Public hospitals 676 (38.8%) 820 (42.1%)
Private health facility 326 (18.7%) 341 (17.5%)
Other health facilities 43 (2.4%) 53 (2.7%)
Not categorized 65 (3.7%) 66 (3.4%)
HIV status Positive 2 (0.001%) 2 (0.001%) P > 0.05
Negative 754 (43.3%) 835 (42.8%)
Unknown 982 (56.5%) 1,111 (57.0%)
Cigarette smoking Yes 91 (5.2%) 114 (5.8%) P > 0.05
No 1,475 (84.8%) 1,694 (86.9%)
Other 172 (9.8%) 140 (7.1%)
Family TB history Yes 78 (4.5%) 89 (4.6%) P > .05
No 1,624 (93.6%) 1,818 (93.3%)
Missing data 33 (1.9%) 41 (2.1%)

In the multiple logistic regression analysis, only BMI values of 30+ (AOR 1.32, 95% CI 1.01–1.73) and being married (AOR 1.99, 95% CI 1.65–2.4) were associated with LTBI (Table 2). Years of service was not associated with LTBI (AOR 1.18, 95% CI 0.97–1.44)].

Discussion

The prevalence of LTBI among health workers in Afghanistan in this study was 47.1%, which is more than double the 23% reported among the global population [23]. There are no recent studies for Afghanistan, but two studies in 1958 and 1978 among children showed that the annual risk of infection was 3.5% [24]. In another survey among six- and seven-year-old children in Kabul, the prevalence of TB infection at a cutoff point of TST 8 mm and above was 4.3% [25].

Our findings are similar to those of studies of HCWs in other high-TB-burden countries. A systematic review of seven countries reported LTBI prevalence in HCWs ranging from 37% in Brazil to 64% in South Africa [21]. LTBI prevalence among HCWs was 36.8% in an Indian tertiary hospital [26]; in Côte d’Ivoire it was 79% [27]; 58.8% in Turkey [28]; 57% in Uganda [29]; and 39.4% in Brazil [30]. In neighboring Iran, however, the prevalence was 24.8% for high-risk workers such as laboratory professionals and 14.8% for low-risk HCWs [31]. Iran and Turkey, however, are low-TB-burden countries, with an incidence of 14 and 17/100,000 respectively [1].

In our study, administrative staff had a higher rate of LTBI, at 35%, followed by 19.3% for nurses, but the difference was not statistically significant (P = 0.2). Other studies reported that housekeeping staff, older health workers, and those working in areas of high patient turnover had higher rates of LTBI [6, 17, 32, 33]. The high LTBI in cleaners, guards, and other administrative staff is probably due to their exposure to patients at registration and in waiting areas as well as high exposure to sputum during cleaning and garbage disposal.

In the bivariate analysis, the factors associated with TB were age, years of professional experience, BMI, marital status, and education level. But in the multivariate analysis, the variables associated with LTBI were BMI and marital status. The AOR for obese participants (BMI ≥ 30) was 1.32 (95% CI 1.01–1.73), while the AOR for those with BMI between 18.0 and 24.9 was 0.83 (95% CI 0.72–0.97). There was no association in our study between LTBI and underweight, a finding which is in line with those of other studies; however, unlike LTBI, TB disease exhibits high prevalence among malnourished persons [34]. Another article reported that the risk of TB increased by 14% for each point reduction in BMI between 18.0 and 29.9, but it not clear whether that is true for those with body mass indexes of < 18 and ≥ 30 [35]. One possible reason for the low LTBI in underweight people could be that impaired immunity in malnourished people prevents reaction to the TST; instead, those with low BMI develop TB disease faster [36]. Cross-sectional studies also cannot show individuals’ BMI histories, so creating an association for a chronic infection like LTBI by measuring BMI at a single point in time may not be appropriate and a longitudinal study would be preferable.

The other LTBI association we found is marital status: the AOR was 1.99 (95% CI 1.65–2.40) for married participants compared to 0.47 (95% CI 0.39–0.57) for single HCWs. Although the reason for the high association of LTBI with marriage is unknown, a similar finding has been reported in South Africa [37]. One reason could be linked to family size and therefore household overcrowding, which might facilitate disease transmission if one member of the household develops TB. Further studies are recommended because there is no plausible reason for married couples to have high LTBI.

In high-TB-burden countries like Afghanistan, where LTBI among HCWs is high, this study should spur action to prevent HCWs from developing TB. Although the benefits of preventive therapy are well established [38, 39]—the protection effectiveness of isoniazid (INH) alone was 90% in studies conducted in developing and developed countries [22]—recommendations for treating HCWs in high-TB-burden countries with ongoing transmission are different from those in low-incidence settings. There is no consensus on treating LTBI among HCWs or in communities in high-TB-burden countries [4]. The WHO’s recently revised LTBI guidelines conditionally recommend that children, adolescents, and adults of all ages who are household contacts of bacteriologically confirmed pulmonary TB cases receive preventive treatment; however, treatment of HCWs is recommended only for low-TB-incidence countries, in part because the re-infection rate is high without a robust TB control program [3]. The lack of easy LTBI diagnostics is another factor for not treating HCWs in high-TB-burden countries.

There is a single experience of community-wide INH preventive therapy, in Alaska between 1958 and 1964, in which the TST prevalence in participating communities was above 80% and the annual risk of infection was 8% at baseline. In this community, daily INH was given for the intervention and placebo given in the control arm for 12 months. The incidence of the disease in the intervention group fell dramatically, and cumulative TB incidence was reduced by 60% [40].

Despite high re-infection rates in high-TB-burden countries, expanding preventive treatment beyond the current recommendation to include high-risk groups such as HCWs and contacts should be considered. The WHO LTBI guidelines conditionally recommend treating children over the age of five, adolescents, and adults in high-TB-burden countries, and Afghanistan can decide to treat HCWs, as they are a high-risk group [3]. Ample evidence shows that providing INH preventive therapy to HIV/AIDS patients and children under five has reduced TB disease, although re-infection is a possibility [5]. Studies in low-incidence settings have shown that INH prophylaxis reduced the development of active TB by 40% over two years or longer [39]. Another article reported that INH preventive therapy reduces the development of active disease by 60% to 90%, depending on treatment adherence levels [41]. All these data favor providing preventive therapy to high-risk groups like HCWs even in high-TB-burden countries like Afghanistan. Environmental, administrative, and personal protection measures to control TB infection that have been implemented in US health care settings associated with TB transmission among patients and HCWs have significantly reduced infections [42], but similar measures are usually poorly implemented in resource-poor countries.

Limitations

Our study has some limitations. We did not get complete information for most of the study subjects about Bacille Calmette-Guérin vaccination, which might affect TST results. Another drawback of this study is measuring BMI in a cross-sectional study and creating an association with LTBI. Cross-sectional studies cannot show individuals’ BMI histories, so creating an association for a chronic infection such as LTBI by measuring the BMI at a single point in time may not be appropriate. We did not include other factors that affect LTBI, such as diabetes mellitus, malignancies, HIV, and other diseases, in our study.

Conclusion

LTBI in HCWs in Afghanistan is very high. Until evidence is generated globally on the effectiveness of targeted treatment of LTBI in high-TB-burden countries or on new sensitive and specific LTBI diagnostics or shorter treatments, we recommend regular screenings of HCWs for active TB and early treatment. Another recommendation is to strengthen the environmental, administrative, and personal protection measures against TB infection that are recommended by the WHO [43].

Acknowledgments

We thank the Afghanistan Ministry of Public Health and NTP and all the health workers, laboratory professionals, and TB program coordinators who participated in this study. Barbara K. Timmons edited the manuscript.

Data Availability

All relevant data are within the paper.

Funding Statement

The United States Agency for International Development (USAID) funded this study through the Challenge TB project under cooperative agreement number AID-OAA-A-14-00029, and the Global Fund to Fight AIDS, Tuberculosis and Malaria provided funding for this study. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government, or the Global Fund . The publication fee is covered by the USAID funded Sustainable Technical and Analytic Resources (STAR) project, through Public Health Institute (PHI).

References

  • 1.World Health Organization (WHO). Global tuberculosis report 2020. Geneva: WHO; 2020. Available from: https://www.who.int/health-topics/tuberculosis#tab=tab. Accessed 24 February 2021. [Google Scholar]
  • 2.WHO. Global tuberculosis report 2017. Geneva: WHO; 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf?sequence=1. Accessed 13 May 2019. [Google Scholar]
  • 3.WHO. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: WHO; 2018. Available from: http://www.ncbi.nlm.nih.gov/books/NBK531235/. Accessed 13 May 2019. [PubMed] [Google Scholar]
  • 4.Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A. Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis. 2011;204(Suppl 4):S1168–78. 10.1093/infdis/jir449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Agaya J, Nnadi CD, Odhiambo J, Obonyo C, Obiero V, Lipke V, et al. Tuberculosis and latent tuberculosis infection among healthcare workers in Kisumu, Kenya. Trop Med Int Health. 2015;20(12):1797–804. 10.1111/tmi.12601 [DOI] [PubMed] [Google Scholar]
  • 6.van Rie A, McCarthy K, Scott L, Dow A, Venter WDF, Stevens WS. Prevalence, risk factors and risk perception of tuberculosis infection among medical students and healthcare workers in Johannesburg, South Africa. South Afr Med J. 2013;103(11):853–7. 10.7196/samj.7092 [DOI] [PubMed] [Google Scholar]
  • 7.Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F. Tuberculosis among health care workers. Emerg Infect Dis. 2011;17(3):488–94. 10.3201/eid1703.100947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Adams S, Ehrlich R, Baatjies R, van Zyl-Smit RN, Said-Hartley Q, Dawson R, et al. Incidence of occupational latent tuberculosis infection in South African healthcare workers. Eur Respir J. 2015;45(5):1364–73. 10.1183/09031936.00138414 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jesudas CD, Thangakunam B. Tuberculosis risk in health care workers. Indian J Chest Dis Allied Sci. 2013;55(3):149–54. [PubMed] [Google Scholar]
  • 10.Yoon CG, Oh SY, Lee JB, Kim MH, Seo Y, Yang J, et al. Occupational risk of latent tuberculosis infection in health workers of 14 military hospitals. J Korean Med Sci. 2017;32(8):1251–7. 10.3346/jkms.2017.32.8.1251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.El-Sokkary RH, Abu-Taleb AM, El-Seifi OS, Zidan HE, Mortada EM, El-Hossary D, et al. Assessing the prevalence of latent tuberculosis among health care providers in Zagazig City, Egypt using tuberculin skin test and QuantiFERON-TB Gold In-Tube Test. Cent Eur J Public Health. 2015;23(4):324–30. 10.21101/cejph.a4101 [DOI] [PubMed] [Google Scholar]
  • 12.Zhou F, Zhang L, Gao L, Hao Y, Zhao X, Liu J, et al. Latent tuberculosis infection and occupational protection among health care workers in two types of public hospitals in China. PLoS One. 2014;9(8):e104673. 10.1371/journal.pone.0104673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhang X, Jia H, Liu F, Pan L, Xing A, Gu S, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in China: a cross-sectional study. PLoS One. 2013;18(6):e66412. 10.1371/journal.pone.0066412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Christopher DJ, James P, Daley P, Armstrong L, Isaac BTJ, Thangakunam B, et al. High annual risk of tuberculosis infection among nursing students in South India: a cohort study. PLoS One. 2011;6(10):e26199. 10.1371/journal.pone.0026199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kizza FN, List J, Nkwata AK, Okwera A, Ezeamama AE, Whalen CC, et al. Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting. BMC Infect Dis. 2015;165. 10.1186/s12879-015-0904-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rafiza S, Rampal KG, Tahir A. Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia. BMC Infect Dis. 2011;18:11:19. 10.1186/1471-2334-11-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sherman HA, Karakis I, Heimer D, Arzt M, Goldstein W, Bouhnik L, et al. Housekeeping health care workers have the highest risk for tuberculin skin test conversion. Int J Tuberc Lung Dis. 2011;1:15(8):1050–5. 10.5588/ijtld.10.0344 [DOI] [PubMed] [Google Scholar]
  • 18.Belo C, Naidoo S. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Nampula Central Hospital, Mozambique. BMC Infect Dis. 2017;17(1): 10.1186/s12879-017-2516-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Grobler L, Mehtar S, Dheda K, Adams S, Babatunde S, van der Walt M, et al. The epidemiology of tuberculosis in health care workers in South Africa: a systematic review. BMC Health Serv Res. 2016;20:16(1):416. 10.1186/s12913-016-1601-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nasreen S, Shokoohi M, Malvankar-Mehta MS. Prevalence of latent tuberculosis among health care workers in high burden countries: a systematic review and meta-analysis. PLoS One. 2016;11(10):e0164034. 10.1371/journal.pone.0164034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Illowsky B, Dean S (senior contributing authors). Introductory statistics. Houston: Rice University; 2018. P. 467. Available from: https://openstax.org/details/books/introductory-statistics. Accessed 9 March 2021. [Google Scholar]
  • 22.American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221–47. 10.1164/ajrccm.161.supplement_3.ats600 [DOI] [PubMed] [Google Scholar]
  • 23.Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152. 10.1371/journal.pmed.1002152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculous infection. 1988. Bull World Health Organ. 2002;80(6):503–11. [PMC free article] [PubMed] [Google Scholar]
  • 25.Dubuis M, Fiekert K, Johnston M, Neuenschwander BE, Rieder HL. A tuberculin skin test survey among Afghan children in Kabul. Int J Tuberc Lung Dis. 2004;8(9):1065–72. [PubMed] [Google Scholar]
  • 26.Janagond A, Ganesan V, Vijay Kumar G, Ramesh A, Anand P, Mariappan M. Screening of health-care workers for latent tuberculosis infection in a tertiary care hospital. Int J Mycobacteriology. 2017;6(3):253. 10.4103/ijmy.ijmy_82_17 [DOI] [PubMed] [Google Scholar]
  • 27.Kassim S, Zuber P, Wiktor SZ, Diomande FV, Coulibaly IM, Coulibaly D, et al. Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Côte d’Ivoire. Int J Tuberc Lung Dis. 2000;4(4):321–6. [PubMed] [Google Scholar]
  • 28.Bozkanat E, Kaya H, Sezer O, Caliskan T, Kilic E, Ciftci F, et al. Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube Test for diagnosis of latent tuberculosis infection in health care workers: a cross sectional study. J Pak Med Assoc. 2016;66(3):270–4. [PubMed] [Google Scholar]
  • 29.Kayanja HK, Debanne S, King C, Whalen CC. Tuberculosis infection among health care workers in Kampala, Uganda. Int J Tuberc Lung Dis. 2005;9(6):686–8. [PubMed] [Google Scholar]
  • 30.Lacerda TC, Souza FM de, Prado TN do, Locatelli RL, Fregona G, Lima R de CD, et al. Tuberculosis infection among primary health care workers. J Bras Pneumol. 2017;43(6):416–23. 10.1590/S1806-37562016000000211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nasehi M, Hashemi-Shahraki A, Doosti-Irani A, Sharafi S, Mostafavi E. Prevalence of latent tuberculosis infection among tuberculosis laboratory workers in Iran. Epidemiol Health. 2016. 30;39:e2017002. 10.4178/epih.e2017002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sawanyawisuth K, Chaiear N, Sawanyawisuth K, Limpawattana P, Bourpoern J, Reechaipichitkul W, et al. Can workplaces be predictors for recent onset latent tuberculosis in health care workers? J Occup Med Toxicol. 2009;4–20. 10.1186/1745-6673-4-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Jo K-W, Hong Y, Park JS, Bae I-G, Eom JS, Lee S-R, et al. Prevalence of latent tuberculosis infection among health care workers in South Korea: a multicenter study. Tuberc Respir Dis. 2013;75(1):18. 10.4046/trd.2013.75.1.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Saag LA, LaValley MP, Hochberg NS, Cegielski JP, Pleskunas JA, Linas BP, et al. Low body mass index and latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018;22(4):358–65. 10.5588/ijtld.17.0558 [DOI] [PubMed] [Google Scholar]
  • 35.Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39(1):149–55. 10.1093/ije/dyp308 [DOI] [PubMed] [Google Scholar]
  • 36.Anuradha R, Munisankar S, Bhootra Y, Kumar NP, Dolla C, Kumaran P, et al. Coexistent malnutrition is associated with perturbations in systemic and antigen-specific cytokine responses in latent tuberculosis infection. Clin Vaccine Immunol. 2016;23(4):339–45. 10.1128/CVI.00009-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ncayiyana JR, Bassett J, West N, Westreich D, Musenge E, Emch M, et al. Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study. BMC Infect Dis. 2016;16(1) 10.1186/s12879-016-1989-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fox GJ, Dobler CC, Marais BJ, Denholm JT. Preventive therapy for latent tuberculosis infection: the promise and the challenges. Int J Infect Dis. 2017;56:68–76. 10.1016/j.ijid.2016.11.006 [DOI] [PubMed] [Google Scholar]
  • 39.Smieja M, Marchetti C, Cook D, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 1999. wiley.com/10.1002/14651858.CD001363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis. 1967;95(6):935–43. 10.1164/arrd.1967.95.6.935 [DOI] [PubMed] [Google Scholar]
  • 41.Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, Woeltje KF, Fraser VJ. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Int J Tuberc Lung Dis. 2011;15(1):14–23. [PubMed] [Google Scholar]
  • 42.Jensen PA, Lambert LA, Iademarco MF, Ridzon R, CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1–141. [PubMed] [Google Scholar]
  • 43.WHO. WHO policy on TB infection control in health-care facilities, congregate settings and households. Geneva: WHO; 2009. [PubMed] [Google Scholar]

Decision Letter 0

Ramesh Kumar

4 Feb 2021

PONE-D-20-33514

Prevalence of latent tuberculosis infection among health workers in Afghanistan: a cross-sectional study

PLOS ONE

Dear Author

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Ramesh Kumar, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.Thank you for stating the following in the Funding Section of your manuscript:

"The United States Agency for International Development (USAID), through the Challenge TB

project under cooperative agreement number AID-OAA-A-14-00029, and the Global Fund to

Fight AIDS, Tuberculosis and Malaria provided funding for this study."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 "The author(s) received no specific funding for this work"

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Additional Editor Comments:

Comments are atteched

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have selected a very important public health problem i.e. Latent tuberculosis among health workers in Afghanistan. There is need of such studies to generate information for devising national strategy/policy regarding undertaking interventions. Some of the suggested changes before publication are as following:

1. For Reference 1 and 2, please incorporate the access-date and as well as link for the access.

2. In Methods-section, remove the word "we". The sample was calculated on the basis of single proportion formula...please elaborate it. Also explain the systematic random sampling of study facilities and thereafter selection of study participants.

3. In Results-section omit words such as 'majority' in 2nd-paragraph 2nd sentence. Just objectively describe the findings. For tables, briefly explain the findings in caption.

4. In Discussion, also compare the findings with relevant studies in the relevant-settings.

Reviewer #2: This manuscript by Qader etal is a well concieved and well written study that takes a look at prevalence of LTBI in healthcare workers in Afganistan. As pointed out by the authors the main corelation of LTBI with BMI maybe transactional. The main results from the study about prevalence of LTBI are not novel but technically sound as per PLOS one policies.

Minor comment: The authors mention as two places that one third of the world population is suspected LTBI, hoever the they also mention recent WHO data that show that number around one fourh (23%). Authors should reference and use the current data from WHO.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 1;16(6):e0252307. doi: 10.1371/journal.pone.0252307.r002

Author response to Decision Letter 0


23 Mar 2021

Reviewer #2

We would like to thank Reviewer #2 for reviewing our article and providing valuable feedback. We have addressed the comments in the following way:

1. Minor comment: The authors mention as two places that one third of the world population is suspected LTBI, however they also mention recent WHO data that show that number around one fourth (23%). Authors should reference and use the current data from WHO.

We updated all the figures with the new WHO report, and actually the current TB infection prediction is 2 billion, which is around 26% of the world population in 2019.

Attachment

Submitted filename: Response to Reviewer #2.docx

Decision Letter 1

Ramesh Kumar

14 May 2021

Prevalence of latent tuberculosis infection among health workers in Afghanistan: a cross-sectional study

PONE-D-20-33514R1

Dear Author,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ramesh Kumar, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Ramesh Kumar

21 May 2021

PONE-D-20-33514R1

Prevalence of latent tuberculosis infection among health workers in Afghanistan: a cross-sectional study

Dear Dr. Qader:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ramesh Kumar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewer #2.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES